GlassScriptPhysician profile
Mary Ella Carter
NPI 1194750224
$3,571.14
in general payments reported to CMS, 2019-2025
18 companies · $2,036 in 2025
The $2,036 reported for 2025 was more than what 84% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $79.78 · 2020: $93.42 · 2021: $376 · 2022: $306 · 2023: $425 · 2024: $255 · 2025: $2,036.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $1,502 · Food and Beverage: $1,213.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $1,501.97 |
| Food and Beverage | $1,213.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $1,987.02 | 2019-2025 | Amnioexcel Plus, Integra, Primatrix |
| Allergan, INC. | $348.84 | 2020-2022 | |
| Kerecis Limited | $176.65 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Baxter Healthcare | $171.43 | 2023 | Artiss |
| Revance Therapeutics, INC. | $159.92 | 2025 | Daxxify |
| Tela Bio, INC. | $127.08 | 2023-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Mentor Worldwide LLC | $100.90 | 2023 | Mentor Cpx 2 Breast Tissue Expander |
| Organogenesis INC. | $77.39 | 2019-2022 | |
| Mimedx Group, INC. | $60.48 | 2024-2025 | |
| Convatec INC. | $59.70 | 2023-2024 | |
| Acera Surgical, INC. | $56.89 | 2021-2022 | |
| Abbvie INC. | $45.68 | 2023-2024 | |
| Regeneron Healthcare Solutions, INC. | $43.11 | 2020-2021 | |
| Smith+Nephew, INC. | $41.88 | 2019-2023 | Stravix Pl, Grafix Pl |
| Hartmann USA, INC. | $36.22 | 2021-2025 | Zetuvit Plus 10x10 P10 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $35.99 | 2021 | |
| Triad Life Sciences INC. | $28.45 | 2022 | |
| Genzyme Corporation | $13.51 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Ella Carter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.